| 2015 |
Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL, Mumm S. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. June 2015;75:229-239. |
18 |
11 |
| 2020 |
Mumm S, Gottesman GS, Wenkert D, Campeau PM, Nenninger A, Huskey M, Bijanki VN, Veis DJ, Barnes AM, Marini JC, Stolina M, Zhang F, McAlister WH, Whyte MP. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation. Bone. January 2020;130:115047. |
2 |
0 |
| 2020 |
Whyte MP, Zhang F, Wenkert D, Mumm S, Berndt TJ, Kumar R. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia. Bone. May 2020;134:115300. |
1 |
0 |
| 2022 |
Whyte MP, Zhang F, Wenkert D, Mack KE, Bijanki VN, Ericson KL, Coburn SP. Hypophosphatasia: vitamin B₆ status of affected children and adults. Bone. January 2022;154:116204. |
0 |
0 |
| 2020 |
Smith PS, Gottesman GS, Zhang F, Cook F, Ramirez B, Wenkert D, Wollberg V, Huskey M, Mumm S, Whyte MP. X‐linked hypophosphatemia: uniquely mild disease associated with PHEX 3′‐UTR mutation c.*231A>G (a retrospective case–control study). J Bone Miner Res. May 2020;35(5):920-931. |
4 |
2 |